Forte Biosciences, Inc. (FBRX)

Market Cap	19.79M
Revenue (ttm)	n/a
Net Income (ttm)	-34.20M
Shares Out	1.46M
EPS (ttm)	-18.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,415,905
Open	10.46
Previous Close	5.56
Day's Range	8.79 - 18.81
52-Week Range	4.11 - 21.25
Beta	1.46
Analysts	Strong Buy
Price Target	77.58 (+472.55%)
Earnings Date	Nov 14, 2024

About FBRX

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Paul A. Wagner
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: FBRX
• Website: https://www.fortebiorx.com

Analyst Forecast

According to 3 analysts, the average rating for FBRX stock is "Strong Buy." The 12-month stock price forecast is $77.58, which is an increase of 472.55% from the latest price.

Price Target

$77.58

(472.55% upside)

Analyst Consensus: Strong Buy